Navigating the evolving landscape of pharmaceutical patient support requires staying ahead of emerging technologies and industry trends. In this illuminating conversation with Cathy Zaremba from Medisafe's Marketing team, we dive into key takeaways from two major industry conferences—Hubs West and Fierce Pharma Week—where changing regulations, digital innovation, and artificial intelligence dominated discussions.
The pharmaceutical conference landscape itself is transforming. Fierce Pharma Week's ambitious combination of four previously separate events created a high-energy environment but revealed growing pains as exhibitors faced logistical challenges with sessions and exhibition halls on separate floors. This raises interesting questions about whether bigger always means better when it comes to industry gatherings.
Artificial intelligence has moved beyond buzzword status to practical implementation discussions. Pharma companies are now asking critical questions about using AI safely within a regulated environment. We explore how Medisafe is answering these questions through patient-facing applications like VIA, an AI assistant that helps patients with medication adherence, education, platform onboarding, and benefits verification—all while maintaining strict regulatory compliance.
The transformation of patient support services through digital tools represents a paradigm shift similar to online banking's evolution. Secure document exchange capabilities now allow patients to upload verification documents directly through support platforms rather than relying on faxes. These innovations streamline processes during high-volume periods like "blizzard season" when many patients need to reaffirm their eligibility for assistance programs.
Ready to discover how technology is transforming patient support while maintaining regulatory compliance? Listen now to gain valuable insights that will help you navigate the future of pharmaceutical patient engagement.
PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.
